Total Clarity Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Total Clarity Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,587	Closed	-$26K	–	268
2022 Q2	$26K	Buy	+2,587	New	+$28.9K	0.01%	511
2022 Q1	–	Sell	-8,437	Closed	-$193K	–	261
2021 Q4	$193K	Buy	8,437 +6,275	+290%	+$149K	0.09%	219
2021 Q3	$48K	Buy	+2,162	New	+$34.3K	0.02%	412
2021 Q2	–	Sell	-11,333	Closed	-$147K	–	228
2021 Q1	$147K	Buy	11,333 +893	+9%	+$13K	0.08%	199
2020 Q4	$144K	Buy	10,440 +52	+0.5%	+$757	0.1%	148
2020 Q3	$153K	Sell	10,388 -525	-5%	-$7.61K	0.13%	123
2020 Q2	$177K	Buy	10,913 +480	+5%	+$7.68K	0.16%	122
2020 Q1	$151K	Sell	10,433 -1,129	-10%	-$19.9K	0.23%	92
2019 Q4	$234K	Buy	+11,562	New	+$107K	0.18%	112

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Total Clarity Wealth Management's AUPH Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2022, closing a stake of 2,587 shares — an estimated $26K sold.

Total Clarity Wealth Management first reported a position in AUPH in Q4 2019 and held it in 9 quarters. The position peaked at $234K in Q4 2019. 189 funds tracked by Wall St. Rank hold AUPH as of Q3 2022.

Total Clarity Wealth Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 2,587 Aurinia Pharmaceuticals shares in Q3 2022, an estimated $26K.
Total Clarity Wealth Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 9 quarters.
Total Clarity Wealth Management's Aurinia Pharmaceuticals position peaked at $234K in Q4 2019.
189 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.